Does Rifampin-Isoniazid 300 Mg-150 Mg Capsule Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- P-GLYCOPROTEIN (P-GP) INHIB/COLCHICINE (CARDIOPROTECTION)
- STRONG CYP3A4 INDUCERS/LENACAPAVIR
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (> 5 MG)
- DUAL STRONG OR MODERATE CYP2C19 & CYP3A4 INDUCERS/MAVACAMTEN
- STRONG CYP3A4 INDUCERS/PACRITINIB
- UGT1A1 INDUCERS/CABOTEGRAVIR
- CYP3A4 & UGT1A1 INDUCERS/CABOTEGRAVIR-RILPIVIRINE
- STRONG AND MODERATE CYP3A4 INDUCERS/LONAFARNIB
- STRONG CYP3A4 INDUCERS/FOSTEMSAVIR
- STRONG CYP3A4 INDUCERS/TAMOXIFEN
- STRONG CYP3A4 INDUCERS/LORLATINIB
- CYP3A4 INDUCERS/DORAVIRINE
- RIFAMPIN/BICTEGRAVIR
- STR CYP3A4 & P-GP INDUCER;PHENOBARB/GLECAPREVIR-PIBRENTASVIR
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>30 MG)
- RIFAMPIN/ELBASVIR-GRAZOPREVIR
- STRONG CYP3A4 INDUCERS/DELAMANID
- RIFAMPIN/OMBITA-PARITAP-RITON-DASABUVIR
- STRONG CYP3A4 INDUCERS/DACLATASVIR
- P-GP INDUCERS; PHENOBARBITAL/SELECTED HEPATITIS C AGENTS
- STRONG CYP3A4 INDUCERS/ARTEMETHER; LUMEFANTRINE
- SELECT CYP3A4 INDUCERS/RILPIVIRINE
- CYP3A4 INDUCERS/SELECTED PROTEASE INHIBITORS; COBICISTAT
- STRONG CYP3A4 INDUCERS/TICAGRELOR; VORAPAXAR
- STRONG CYP3A4 INDUCERS/LURASIDONE
- RIFAMPIN/PITAVASTATIN (> 2 MG)
- SELECTED CYP3A4 INDUCERS/NIFEDIPINE
- RIFAMPIN; RIFAPENTINE/PRAZIQUANTEL
- STRONG CYP3A4 INDUCERS/RANOLAZINE
- SELECTED STRONG CYP3A4 INDUCERS/NIMODIPINE
- RIFAMPIN; RIFAPENTINE/ETRAVIRINE; NEVIRAPINE
- ISONIAZID/ITRACONAZOLE; KETOCONAZOLE; LEVOKETOCONAZOLE
- SELECTED CYP3A4 INDUCERS/ISAVUCONAZONIUM; VORICONAZOLE
- RIFAMPIN; RIFABUTIN/DELAVIRDINE
- RIFAMPIN/SELECTED CYP3A4 SUBSTRATES
- ANTIMICROBIALS/LIVE TYPHOID VACCINE
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- RIFAMYCINS/SELECTED ANTICOAGULANTS (VITAMIN K ANTAGONISTS)
- RIFAMPIN/PYRAZINAMIDE
- RIFAMPIN/CLARITHROMYCIN; ERYTHROMYCIN; TELITHROMYCIN
- STRONG CYP3A4 INDUCERS/LERCANIDIPINE
- DUAL STRONG CYP3A4 INDUCERS AND P-GP INHIBITORS/MAVORIXAFOR
- STRONG AND MODERATE CYP2C8 INDUCERS/TOVORAFENIB
- STRONG AND MODERATE CYP3A4 INDUCERS/LEMBOREXANT
- STRONG AND MODERATE CYP3A4 INDUCERS/NIROGACESTAT
- STRONG OR MODERATE CYP3A4 INDUCERS/REPOTRECTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/CAPIVASERTIB
- STRONG CYP3A4 INDUCERS/FRUQUINTINIB
- COMBINED CYP2C8; CYP2C9; CYP3A4 INDUCERS/ETRASIMOD
- STRONG CYP3A4 INDUCERS/GEPIRONE
- CYP3A4 INDUCERS/ZURANOLONE
- STRONG & MODERATE CYP3A4 INDUCERS/QUIZARTINIB
- STRONG CYP3A4 INDUCERS/VINCRISTINE
- STRONG CYP3A4 INDUCERS/PANOBINOSTAT
- STRONG CYP3A4 INDUCERS/PACLITAXEL
- STRONG CYP3A4 INDUCERS/DOXORUBICIN
- STRONG CYP3A4 INDUCERS/DOCETAXEL
- STRONG CYP3A4 INDUCERS/CABAZITAXEL
- STRONG & MODERATE CYP3A4 INDUCERS/SONIDEGIB
- STRONG & MODERATE CYP3A4 INDUCERS/PALBOCICLIB
- STRONG & MODERATE CYP3A4 INDUCERS/OLAPARIB
- STRONG CYP3A4 INDUCERS/VANDETANIB
- STRONG CYP3A4 INDUCERS/SUNITINIB
- STRONG CYP3A4 INDUCERS/SORAFENIB
- STRONG CYP3A4 INDUCERS/PAZOPANIB
- STRONG CYP3A4 INDUCERS/NILOTINIB
- STRONG CYP3A4 INDUCERS/IDELALISIB
- STRONG CYP3A4 INDUCERS/IBRUTINIB
- STRONG CYP3A4 INDUCERS/GEFITINIB
- CYP3A4 INDUCERS/ERLOTINIB
- STRONG CYP3A4 INDUCERS/DASATINIB
- STRONG CYP3A4 INDUCERS/CRIZOTINIB
- STRONG CYP3A4 INDUCERS/CERITINIB
- STRONG CYP3A4 INDUCERS/CABOZANTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/PALOVAROTENE
- STRONG CYP3A4 INDUCERS/RITLECITINIB
- STRONG & MODERATE CYP3A4 INDUCERS/AXITINIB
- STRONG CYP3A4 INDUCERS/LAPATINIB
- STRONG CYP3A4 INDUCERS/IMATINIB
- STRONG CYP3A4 INDUCERS/TRETINOIN
- ANTIBIOTICS/FECAL MICROBIOTA SPORES
- STRONG AND MODERATE CYP3A4 INDUCERS/LENIOLISIB
- OATP1B3 INHIBITORS/ZAVEGEPANT
- STRONG AND MODERATE CYP3A4 INDUCERS/OMAVELOXOLONE
- STRONG CYP3A4 INDUCERS/SPARSENTAN
- STRONG AND MODERATE CYP3A4 INDUCERS/ELACESTRANT
- STRONG CYP3A4 INDUCERS/PIRTOBRUTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/CARIPRAZINE
- STRONG CYP3A4 INDUCERS/ADAGRASIB
- STRONG AND MODERATE CYP3A4 INDUCERS/OLUTASIDENIB
- DUAL P-GP & STRONG 3A4 INDUCERS/FUTIBATINIB
- STRONG CYP3A4 INDUCERS/THIOTEPA
- STRONG CYP3A4 INDUCERS/SAVOLITINIB
- STR OR MOD 3A4 INDUCER/VONOPRAZAN-CLARITHROMYCIN-AMOXICILLIN
- STRONG OR MODERATE CYP3A4 INDUCERS/VONOPRAZAN
- WEAK CYP2C19 INHIBITORS/MAVACAMTEN
- STRONG CYP3A4 INDUCERS/ALPELISIB
- STRONG OR MODERATE CYP3A4 INDUCERS/GANAXOLONE
- STRONG CYP3A4 INDUCERS/MITAPIVAT
- STRONG CYP3A4 INDUCERS/CYCLOPHOSPHAMIDE
- STRONG CYP3A4 INDUCERS/RIVOCERANIB
- STRONG CYP2C9 OR CYP2C19 INDUCERS/ABROCITINIB
- STRONG CYP3A4 INDUCERS/LEVOKETOCONAZOLE
- STRONG CYP3A4 INDUCERS/TADALAFIL (BPH, PAH)
- SELECTED STRONG CYP3A4 INDUCERS/MARIBAVIR
- STRONG CYP3A4 INDUCERS/SURUFATINIB
- STRONG OR MODERATE CYP3A4 INDUCERS/AVACOPAN
- ENCORAFENIB; RIFAMPIN/ATOGEPANT
- STRONG OR MODERATE CYP3A4 INDUCERS/MOBOCERTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/FEXINIDAZOLE
- STRONG AND MODERATE CYP3A4 INDUCERS/FINERENONE
- STRONG AND MODERATE CYP3A4 INDUCERS/IBREXAFUNGERP
- OATP1B1-3 INHIBITORS/BRINCIDOFOVIR
- STRONG CYP3A4 INDUCERS/SAMIDORPHAN
- STRONG AND MODERATE CYP3A4 INDUCERS/INFIGRATINIB
- STRONG CYP3A4 INDUCERS/SOTORASIB
- DUAL P-GP & STRONG 3A4 INDUC/RELUGOLIX-HORMONAL COMBINATIONS
- RIFAMYCINS/DAPSONE
- SELECTED STRONG CYP3A4 INDUCERS/APREPITANT; NETUPITANT
- STRONG AND MODERATE CYP3A4 INDUCERS/VOCLOSPORIN
- P-GP AND STRONG CYP3A4 INDUCERS/RELUGOLIX
- SELECTED P-GP INDUCERS/BEROTRALSTAT
- STRONG CYP3A4 INDUCERS/LUMACAFTOR-IVACAFTOR
- STRONG CYP3A4 INDUCERS/PRALSETINIB
- SELECTED STRONG CYP2C19 INDUCERS/CLOPIDOGREL
- STRONG CYP3A4 INDUCERS/PLITIDEPSIN
- RIFAMPIN; RIFAPENTINE/ATOVAQUONE
- STRONG CYP1A2, CYP2B6 OR CYP3A4 INDUCERS/FENFLURAMINE
- STRONG CYP3A4 INDUCERS/LURBINECTEDIN
- STRONG CYP3A4 INDUCERS/RIPRETINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/SELPERCATINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/CAPMATINIB
- UGT1A1 INDUCERS/SACITUZUMAB GOVITECAN
- STRONG CYP3A4 INDUCERS; MODERATE CYP2C8 INDUCERS/TUCATINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/SELUMETINIB
- MODERATE CYP2C8 INDUCERS/OZANIMOD
- STRONG AND MODERATE CYP3A4 INDUCERS/RIMEGEPANT
- STRONG OR MODERATE CYP3A4 INDUCERS/TAZEMETOSTAT
- STRONG CYP3A4 INDUCERS/REGORAFENIB
- STRONG OR MODERATE CYP3A4 INDUCERS/AVAPRITINIB
- CYP3A4 INDUCERS/LUMATEPERONE
- STRONG OR MODERATE CYP3A4 INDUCERS/DARIDOREXANT
- STRONG CYP3A4 INDUCERS/UBROGEPANT
- SELECTED STRONG OR MODERATE CYP3A4 INDUCERS/VOXELOTOR
- STRONG CYP3A4 INDUCERS/ZANUBRUTINIB
- P-GLYCOPROTEIN (P-GP) OR UGT INDUCERS/LETERMOVIR
- SELECTED STRONG CYP3A4 INDUCERS/ISTRADEFYLLINE
- STRONG CYP3A4 OR P-GLYCOPROTEIN (P-GP) INDUCER/LEFAMULIN
- STRONG CYP3A4 INDUCERS/FEDRATINIB
- STRONG CYP3A4 INDUCERS/UPADACITINIB
- STRONG CYP3A4 INDUCERS/ENTRECTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/PRETOMANID
- SELECTED P-GLYCOPROTEIN (P-GP) INDUCERS/BETRIXABAN
- STRONG CYP3A4 INDUCERS/PEXIDARTINIB
- P-GP AND STRONG CYP3A4 INDUCERS/DAROLUTAMIDE
- DUAL INDUCERS OF CYP2C9 AND CYP3A4/AVATROMBOPAG
- STRONG CYP3A4 INDUCERS/TIVOZANIB
- STRONG CYP3A4 INDUCERS/ERDAFITINIB
- DUAL INDUCERS OF CYP2C9 AND CYP3A4/SIPONIMOD
- P-GP AND STRONG CYP3A4 INDUCERS/GILTERITINIB
- STRONG CYP3A4 INDUCERS; RIFABUTIN/LAROTRECTINIB
- STRONG CYP3A4 INDUCERS/GLASDEGIB
- WEAK CYP3A4 INHIBITORS/ELIGLUSTAT
- STRONG CYP3A4 INDUCERS/DUVELISIB
- STRONG CYP3A4 INDUCERS/ERAVACYCLINE
- RIFAMPIN/ELAGOLIX
- STRONG CYP3A4 INDUCERS/IVOSIDENIB
- STRONG CYP3A4 INDUCER/SLT LONG-ACTING ARIPIPRAZOLE INJECTION
- STRONG CYP3A4 INDUCERS/ENCORAFENIB
- STRONG CYP3A4 INDUCERS/FOSTAMATINIB
- STRONG 2C19 AND 3A4 INDUCERS/SLT PROTON PUMP INHIBITORS
- STRONG CYP3A4 INDUCERS/MACIMORELIN
- STRONG CYP3A4 INDUCERS/ACALABRUTINIB
- STRONG CYP3A4 INDUCERS/ABEMACICLIB
- STRONG CYP3A4 INDUCERS/COPANLISIB
- STRONG AND MODERATE CYP3A4 INDUCERS/NERATINIB
- P-GLYCOPROTEIN (P-GP) INDUCERS/ETOPOSIDE
- STRONG CYP3A4 INDUCERS; RIFABUTIN/BRIGATINIB
- STRONG CYP3A4 INDUCERS/MIDOSTAURIN
- STRONG CYP3A4 INDUCERS/VALBENAZINE
- STRONG CYP3A4 INDUCERS/NALDEMEDINE
- STRONG CYP3A4 INDUCERS/RIBOCICLIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/COLCHICINE
- ISONIAZID/CLOPIDOGREL
- STRONG AND MODERATE CYP3A4 INDUCERS/PIMAVANSERIN
- STRONG CYP3A4 INDUCERS/VENETOCLAX
- STRONG CYP3A4 INDUCERS; RIFABUTIN/VEMURAFENIB
- STRONG CYP3A4 INDUCERS/TOFACITINIB
- SLT MODERATE AND STRONG CYP3A4 INDUCERS/IXAZOMIB
- STRONG CYP3A4 INDUCERS/OSIMERTINIB
- STRONG CYP3A4 INDUCERS/TRABECTEDIN
- STRONG CYP3A4 INDUCERS/FLIBANSERIN
- OATP1B1 INHIBITORS/ELUXADOLINE
- RIFAMPIN/EDOXABAN
- SELECT CYP2C19 AND CYP3A4 INDUCER/ESOMEPRAZOLE; OMEPRAZOLE
- STRONG CYP3A4 INDUCERS/ABIRATERONE
- STRONG CYP3A4 INDUCERS/NALOXEGOL
- P-GP AND STRONG CYP3A4 INDUCERS/NINTEDANIB
- STRONG CYP3A4 INDUCERS/ELIGLUSTAT
- STRONG CYP3A4 INDUCERS/RAMELTEON; SUVOREXANT; TASIMELTEON
- STRONG CYP3A4 INDUCERS/QUETIAPINE (> 150 MG)
- STRONG & MODERATE CYP3A4 INDUCERS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INDUCERS/SIMEPREVIR
- RIFAMPIN/ROMIDEPSIN
- RIFAMPIN/VALPROIC ACID
- SELECTED UGT1A & CYP3A4 INDUCERS/DOLUTEGRAVIR
- UGT INDUCERS/CANAGLIFLOZIN
- STRONG & MODERATE CYP3A4 INDUCERS/BEDAQUILINE
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (<=30MG)
- STRONG CYP3A4 INDUCERS; RIFABUTIN/PONATINIB
- STRONG CYP3A4 INDUCERS/ENZALUTAMIDE
- SELECTED STRONG CYP3A4 INDUCERS/BORTEZOMIB
- STRONG CYP3A4 INDUCERS/IVACAFTOR
- STRONG & MODERATE CYP3A4 INDUCERS/COBIMETINIB
- SELECT CYP2C19 INHIBITORS/CITALOPRAM (>20 MG)
- P-GP & STRONG 3A4 INDUCERS;EFAVIRENZ;PB/APIXABAN;RIVAROXABAN
- STRONG CYP3A4 INDUCERS/TOREMIFENE
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ALISKIREN
- STRONG P-GP OR CYP3A4 INDUCER/LINAGLIPTIN
- P-GLYCOPROTEIN (P-GP) INDUCERS/DABIGATRAN
- STRONG CYP3A4 INDUCERS/APREMILAST; ROFLUMILAST
- RIFAMYCINS/IXABEPILONE
- RIFAMPIN/VINFLUNINE
- STRONG UGT INDUCERS/DEFERASIROX
- RIFAMPIN/MYCOPHENOLATE
- RIFAMYCINS/ULIPRISTAL
- RIFAMPIN; RIFAPENTINE/AMIODARONE; DRONEDARONE
- STRONG CYP3A4 INDUCERS/TOLVAPTAN
- STRONG CYP3A4 INDUCERS/SELECTED IMMUNOSUPPRESSANTS
- RIFAMPIN/TERBINAFINE
- RIFAMPIN/FESOTERODINE
- SELECTED ANTIMYCOBACTERIALS/LIVE BCG
- STRONG CYP3A4 INDUCERS/MARAVIROC
- STRONG CYP3A4 INDUCERS/MACITENTAN
- SELECTED STRONG CYP3A4 INDUCERS/IRINOTECAN
- RIFAMYCINS/POSACONAZOLE
- STRONG CYP3A4 INDUCERS/BOSUTINIB
- STRONG CYP3A4 INDUCERS/IVABRADINE
- ISONIAZID/CARBAMAZEPINE
- STRONG CYP3A4 INDUCERS/EXEMESTANE
- STRONG CYP3A4 INDUCERS/SELECTED ANTIPSYCHOTICS
- STRONG CYP3A4 INDUCERS/ROLAPITANT
- RIFAMPIN; RIFAPENTINE/BRIVARACETAM; LAMOTRIGINE; PERAMPANEL
- STRONG CYP3A4 INDUCERS/MIFEPRISTONE
- SELECTED RIFAMYCINS/AZOLE ANTIFUNGAL AGENTS
- RIFAMYCINS/THEOPHYLLINE
- RIFAMPIN/HALOTHANE
- RIFAMYCINS/SELECTED CALCIUM CHANNEL BLOCKERS
- SELECTED CYP1A2 AND CYP3A4 INDUCERS/CLOZAPINE
- STR 3A4 INDUCER;SLT BARBITURATES,HYDANTOIN/SLT ANTIMALARIALS
- RIFAMYCINS/HYDANTOINS
- RIFAMYCINS/HORMONAL CONTRACEPTIVES
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- RIFAMPIN/BARBITURATES
- STRONG CYP3A4 INDUCERS/RISPERIDONE INTRAMUSCULAR MONTHLY
- STRONG CYP3A4 INDUCERS/BELUMOSUDIL (400 MG)
- OATP1B1-3 INHIBITORS/MOMELOTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/SILDENAFIL (PAH)
- MODERATE CYP2B6 INDUCERS/BUPROPION COMBINATIONS
- SLT MODERATE AND WEAK CYP3A4 INHIBIT/SIROLIMUS PROTEIN-BOUND
- STRONG CYP3A4 INDUCERS/BELUMOSUDIL
- SLT DUAL CYP2C19 & CYP3A4 INDUCERS/CITALOPRAM; ESCITALOPRAM
- SELECTED STRONG CYP3A4 INDUCERS/HALOPERIDOL
- STRONG UGT INDUCERS; NEVIRAPINE/ARTESUNATE
- SELECTED STRONG CYP3A4 INDUCERS/LEVOMETHADYL
- CYP2B6 AND SELECTED CYP3A4 INDUCERS/LEVOMETHADONE; METHADONE
- STRONG CYP3A4 INDUCERS/CANNABIDIOL; TETRAHYDROCANNABINOL
- WEAK CYP3A4 INHIBITORS/UBROGEPANT
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (<= 5 MG)
- MODERATE AND WEAK CYP3A4 INHIBITORS/TACROLIMUS
- STRONG CYP3A4 INDUCERS/PITOLISANT
- CARBAMAZEPINE; RIFAMPIN/VORTIOXETINE
- SELECTED UGT AND STRONG CYP3A4 INDUCERS/OXCARBAZEPINE
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (<= 15 MG)
- RIFAMPIN/SELEXIPAG
- RIFAMYCINS/ESTROGEN REPLACEMENT THERAPY
- SELECTED CYP1A2 INDUCERS/OLANZAPINE
- SELECTED P-GP INDUCERS; PHENOBARBITAL/TENOFOVIR ALAFENAMIDE
- RIFAMPIN/THYROID PREPARATIONS
- STRONG CYP3A4 INDUCERS/VILAZODONE
- P-GLYCOPROTEIN (P-GP) INDUCERS; PHENOBARBITAL/AFATINIB
- SELECTED CYP2C AND CYP3A4 INDUCERS/OSPEMIFENE
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (> 15 MG)
- MODERATE CYP2B6 INDUCERS/BUPROPION
- SELECTED CYP2C19 INHIBITORS/CITALOPRAM (<= 20 MG)
- SELECTED CYP3A4 INDUCERS/SELECTED BENZODIAZEPINES
- RIFAMPIN/LEFLUNOMIDE
- RIFAMPIN/PITAVASTATIN (<= 2 MG)
- RIFAMPIN/LINEZOLID
- RIFAMPIN/RALTEGRAVIR
- ISONIAZID/ACETAMINOPHEN
- STRONG CYP3A4 INDUCERS/SELECT SEDATIVE HYPNOTICS; BUSPIRONE
- RIFAMPIN/CASPOFUNGIN
- SELECTED STRONG CYP3A4 INDUCERS/SELECTED OPIOIDS
- RIFAMYCINS/BETA-BLOCKERS, ORAL
- RIFAMYCINS/DIGITALIS GLYCOSIDES
- RIFAMYCINS/DISOPYRAMIDE; MEXILETINE; PROPAFENONE
- RIFAMYCINS/PIOGLIT; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA
- CYP3A4 INDUCERS/DOXYCYCLINE
- ISONIAZID/HYDANTOINS
- SELECTED CYP3A4 INDUCERS/CORTICOSTEROIDS
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.